Rituximab Trend 2026

Rituximab is a targeted biologic therapy that binds to CD20 on B-cells, helping the immune system destroy abnormal cells. It treats non-Hodgkin lymphoma, rheumatoid arthritis, and certain autoimmune disorders. Administered intravenously, it reduces inflammation and slows disease progression. Patients with blood cancers or refractory autoimmune conditions often benefit from this treatment.